Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03557918
Title Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Matthew Galsky
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Washington District of Columbia 20057 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
University of Kansas Medical Center Research Institute, Inc. Westwood Kansas 66205 United States Details
Dana Farber- Partners Cancer Care, Inc Boston Massachusetts 02215 United States Details
Ichan School of Medicine at Mount Sinai New York New York 10029-6542 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 United States Details
Huntsman Cancer Institute University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field